| ABR | auditory brainstem responses |
| AD | Alzheimers disease |
| AGEs | advanced glycation end products |
| CAPD | chronic ambulatory peritoneal dialysis |
| CFS | chronic fatigue syndrome |
| CL | cardiolipin |
| CoQ10 | coenzyme Q10 |
| CVD | cardiovascular disease |
| DAG | diacylglycerol |
| DAMPs | damage associated molecular patterns |
| DHA | docosahexaenoic acid |
| EPA | eicosapentaenoic acid |
| EPL | essential phospholipids |
| ETC | electron transport chain |
| FA | fatty acid |
| FDA | US Federal Drug Administration |
| GPL | glycerolphospholipids |
| GRAS | generally recognized as safe |
| HDL | high density lipoproteins; HNE 4-hydroxynonenal |
| IL | interleukin |
| MDA | malondialdehyde |
| MetSyn | metabolic syndrome |
| MIM | mitochondrial inner membrane |
| MLR | membrane lipid replacement |
| mPTP | mitochondrial permeability transition pores |
| mtDNA | mitochondrial DNA |
| NCD | non-communicable diseases |
| NF-κB | nuclear factor kappa B |
| PC | phosphatidylcholine |
| PE | phosphatidylethanolamine |
| PG | phosphatidylglycerol |
| PI | phosphatidylinositol |
| PS | phosphatidylserine |
| RNS | reactive nitrogen species |
| ROS | reactive oxygen species |
| TNFα | tumor necrosis factor alpha |
| T2D | type 2 diabetes |